Metropolis Healthcare surges on getting nod to acquire Hitech

18 Jan 2021 Evaluate

Metropolis Healthcare is currently trading at Rs. 2204.40, up by 40.40 points or 1.87% from its previous closing of Rs. 2164.00 on the BSE.

The scrip opened at Rs. 2210.00 and has touched a high and low of Rs. 2281.00 and Rs. 2188.85 respectively. So far 4869 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2321.00 on 24-Nov-2020 and a 52 week low of Rs. 993.20 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 2224.20 and Rs. 2106.05 respectively. The current market cap of the company is Rs. 11059.51 crore.

The promoters holding in the company stood at 50.39%, while Institutions and Non-Institutions held 41.83% and 7.78% respectively.

Metropolis Healthcare has received approval for acquisition of entire 100% stake in Dr. Ganesan’s Hitech Diagnostic Centre and its subsidiary (Hitech) from its existing promoters and shareholders. The consideration will be discharged partly by cash and partly by issuance of equity shares of the company. The board of director of the company in their meeting held on January 17, 2021 has approved the same.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
 


Metropolis Health. Share Price

1699.95 -25.80 (-1.50%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 407.30
Apollo Hospital Ent. 6347.35
Max Healthcare Inst 820.40
Narayana Hrudayalay 1293.60
Global Health 1323.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.